Targeted Nanoparticles for Imaging Incipient Pancreatic Ductal Adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) carries an extremely poor prognosis, typically presenting with metastasis at the time of diagnosis and exhibiting profound resistance to existing therapies. The development of molecular markers and imaging probes for incipient PDAC would enable ear...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, Kimberly A, Bardeesy, Nabeel, Anbazhagan, Rajesh, Gurumurthy, Sushma, Berger, Justin, Alencar, Herlen, DePinho, Ronald A, Mahmood, Umar, Weissleder, Ralph
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292750/
https://www.ncbi.nlm.nih.gov/pubmed/18416599
http://dx.doi.org/10.1371/journal.pmed.0050085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292750/
https://www.ncbi.nlm.nih.gov/pubmed/18416599
http://dx.doi.org/10.1371/journal.pmed.0050085

Ejemplares similares